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Nationally representative study 
A B S T R A C T   
Background: : The impact of the coronavirus disease 2019 (COVID-19) on the mental health of the US population 
is unclear. This study drew on two nationally representative samples to compare the prevalence rate of anxiety in 
the U.S. before and during the 2020 COVID-19 pandemic. 
Methods: : The Generalized Anxiety Disorder-2 (GAD-2) screening tool was used to detect the proportion of US 
adults screening positive for high levels of anxiety symptoms. Anxiety symptoms was assessed in 2019 using the 
National Health Interview Survey (NHIS; N = 30,915) and during the pandemic using biweekly surveys collected 
as part of the Understanding America Study (UAS; N=8,022 Obs.=121,768) between March and December 2020. 
Results: : The proportion of participants with high levels of anxiety symptoms increased significantly from 8.1% 
(95% CI[7.7, 8.5]) in 2019 to 21.4% (95% CI[19.9, 22.9]) at the beginning of April, 2020. The prevalence then 
declined to 11.4% (95% CI[10.3, 12.5]) in May and remained 3% above 2019 levels until December 2020. This 
pattern of increasing anxiety between 2019 and April 2020 followed by a rapid decrease in anxiety was identified 
across all demographic characteristics examined. 
Limitations: : The NHIS and UAS samples differ in their sampling and mode of administration which may bias 
comparisons between samples. 
Conclusions: : Anxiety symptoms increased markedly during the onset of the COVID-19 pandemic and reduced 
quickly as stay-at-home orders were lifted. These findings highlight the importance of providing mental health 
supports during future lockdowns and suggest that resilience in mental health may have been a key population- 
level response to the demands of the pandemic.   
Introduction  
As of March 2021, the coronavirus disease 2019 (COVID-19) 
pandemic has led to almost 30 million confirmed cases of the virus and 
535,000 deaths in the U.S. (OWID, 2021). Mandatory stay-at-home or-
ders and physical distancing policies launched to curtail the virus spread 
have profoundly disrupted daily life. Nations across the globe have been 
faced with job losses, economic uncertainty, and the social isolation of 
citizens (Altig et al., 2020; Robinson & Daly, 2020). For these reasons, it 
has been widely predicted by experts and the media that the pandemic 
may have severe and long-lasting mental health effects (Holmes et al., 
2020; O’Connor et al., 2020). 
However, to date, there is relatively little direct evidence in support 
of this idea. A high prevalence of anxiety, depression, and post- 
traumatic disorder has been repeatedly reported over the course of the 
pandemic in studies relying largely on convenience samples or without 
comparable pre-pandemic assessments (Vindegaard et al., 2020). Due to 
the lack of large-scale nationally representative studies with data before 
and during the pandemic it is unclear whether the prevalence of psy-
chiatric conditions has increased throughout the pandemic. Three 
multi-wave probability-based general population studies have shown 
that psychological distress and depression increased as the pandemic 
emerged in the U.S. (Daly et al., 2021b; Ettman et al., 2020; McGinty 
et al., 2020). A fourth study found that the proportion of adults re 
reporting high levels of anxiety or depressive symptoms increased over 
three-fold between 2019 and April-May 2020 in the U.S. (Twenge & 
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Joiner, 2020). 
While these studies have shown that substantial numbers of U.S. 
adults reported worsening mental health in the initial weeks of the 
pandemic, the longer-term effects as the pandemic progressed remain 
unclear. The above increase in anxiety and depressive symptoms 
occurred while unprecedented restrictions on travel were introduced, 
schools and universities were closed, and mandatory stay-at-home or-
ders were being issued in most states (Tolbert et al., 2020), but less is 
known about mental health as restrictions were eased after the initial 
period of the pandemic. 
In this study, we therefore examine the prevalence of anxiety 
symptoms in two US probability-based nationally representative sam-
ples over the course of 2020 (i.e. March - December 2020) compared to 
2019 pre-pandemic data, in order to chart the longitudinal profile of 
population level anxiety during the 2020 COVID pandemic. 
Methods 
Sample 
The National Heath Interview Survey (NHIS) is an annual, cross- 
sectional, in-person survey administered by the National Center for 
Health Statistics (NCHS) within the Centers for Disease Control and 
Prevention (CDC). The NHIS uses a stratified cluster probability design 
to obtain a nationally representative sample of noninstitutionalized ci-
vilians. NHIS data is collected continuously throughout the year and the 
sample is designed to produce nationally representative samples for 
each quarter. The NHIS is a key source of up-to-date information on 
health trends in the United States and the 2019 sample includes 31,997 
adults. We excluded 3.4% of observations with missing anxiety or co-
variate data and the sample size for the current study was 30,915. 
The Understanding American Study (UAS) is a national probability- 
based sample of US adults recruited via address-based sampling from the 
U.S. Postal Service Computerized Delivery Sequence file (Alattar et al., 
2018). The UAS is a longitudinal online study and eligible participants 
without internet access are provided with internet-enabled tablets to 
ensure sample representativeness. Of a total of 8,815 panel members 8, 
131 provided data as part of the UAS COVID-19 study. From March 10, 
2020 to December 31, 2020 UAS participants were invited to participate 
in 20 biweekly surveys and participants submitted approximately 15 
surveys on average over this period (total responses = 124,685). In this 
study we excluded 109 participants and 2,899 observations (2.3% of 
total responses) due to missing anxiety or covariate data leaving a 
sample size of 8,022 adults and 121,768 responses for the current study. 
The NHIS and UAS samples were broadly comparable on age, gender, 
and race/ethnicity, as shown in Table S1. However, the UAS included a 
larger portion of participants with a college degree and the NHIS sample 
included a larger portion of adults with household income levels ≥
$50,000 and ‘Other’ race/ethnicity participants. This study involved 
secondary analysis of the NIHS and UAS anonymized microdata files 
which did not require institutional approval from the Maynooth Uni-
versity Social Research Ethics Sub-Committee. 
Measures 
Demographic characteristics 
Participants reported their age (grouped into 18-39, 40-59, and 60+
years), sex (male, female), race/ethnicity (White, Hispanic, Black, Asian, 
other race/ethnicity), education (college degree, no degree) and 
household income levels (low income = $0-$49,999, high income =
$50,000+ per annum). 
Anxiety 
Participants completed the validated Generalized Anxiety Disorder 
(GAD-2) screening measure for assessing anxiety in the general popu-
lation (Donker et al., 2011). The GAD-2 items ask how often in the past 2 
weeks participants have been bothered by core anxiety symptoms: 
“feeling nervous, anxious, or on edge” and “not being able to stop or 
control worrying”. Both items were rated on a scale with response op-
tions not at all = 0, several days = 1, more than half of days = 2, and nearly 
every day = 3. Response to both items were summed to give a score from 
0-6 with scores ≥ 3 classed as above the validated threshold for 
detecting probable cases of GAD (sensitivity = .86, specificity = .83) 
(Donker et al., 2011). A recent diagnostic meta-analysis has shown that 
the GAD-2 cut-off of ≥ 3 optimally balances sensitivity (0.76) and 
specificity (0.81) for detecting GAD (Plummer et al., 2016). 
Analytical strategy 
We first compared the prevalence of anxiety in the NHIS in each 
quarter of 2019 and at each of 20 time-points in the UAS. Specifically, 
we estimated the weighted percentage of the sample with anxiety with 
95% confidence intervals for the overall sample for each time-period. 
Our initial analyses indicated that anxiety levels were highly stable 
and did not change significantly from May to December 2020 (see 
Figure 1). For this reason, we focused our in-depth analyses of changes 
in anxiety levels on the UAS survey waves at the pandemic onset (i.e. 
March – May, 2020) and six months later in December 2020. Logistic 
regression analysis followed by the margins post-estimation command 
was used to estimate changes in the prevalence of anxiety from 2019 
levels over the course of the pandemic. 
In the NHIS and UAS survey sampling weights were applied to adjust 
for the differential probabilities of selection into the survey and to align 
the sample with the distribution of demographic characteristics in the 
US civilian population. A comprehensive account of the weighting 
methodologies can be found in Bramlett et al. (2020) and Angrisani 
et al. (2019). 
Results 
The proportion of adults experiencing anxiety in the U.S. was stable 
throughout 2019 (min. = 7.7%, max. = 8.3%) and then increased from 
an average of 8.1% (95% CI[7.7, 8.5]) in 2019 to 15.8% (95% CI[14.6, 
17.0]) in March 2020 and rose to 21.4% (95% CI[19.9, 22.9]) in the first 
half of April (see Table 1 and Figure 1). Anxiety levels then declined 
significantly to 11.4% (95% CI[10.3, 12.5]) in May (13-26) and 
remained at this level until December 2020, as can be seen in Figure 1. 
Statistically significant increases in the prevalence of anxiety be-
tween 2019 and April 1-14, 2020 were identified across all population 
subgroups examined, as shown in Table 1. Anxiety levels increased most 
sharply over this period in young adults aged 18-39 (16.1% increase, 
95% CI[13.2, 19.1], p <.001), Hispanic participants (17.3%, 95% CI 
[12.2, 22.4], p <.001), and females (15.2%, 95% CI[13.0, 17.5], p 
<.001). In contrast, the smallest increases in anxiety were found 
amongst older adults aged 60+ (7.9%, 95% CI[5.7, 10.1], p <.001) and 
Black participants (7.1%, 95% CI[2.9, 11.4], p <.01). 
The sharp decline in the prevalence of anxiety between April 1-14 
and May 13-26 was statistically significant in the overall sample (10% 
decrease, 95% CI[8.4, 11.6], p <.001) and for each population subgroup 
examined with the exception of ‘Other race/ethnicity’ participants (see 
Table S2), potentially reflecting the small size of this group. The prev-
alence of anxiety remained 3.2% (95% CI[2.0, 4.4], p <.001) above 
2019 levels in December 2020. At this time, the prevalence of anxiety 
was significantly above 2019 levels for all population subgroups with 
the exception of older adults, Black, and Hispanic participants. Older 
adults and Back participants showed close to complete recovery to pre- 
pandemic anxiety levels, as shown in Table 1. 
Discussion 
This study aimed to track how reports of anxiety symptoms changed 
from pre-pandemic levels throughout the COVID-19 pandemic in 2020. 
Drawing on two nationally representative probability-based samples we 
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showed that U.S. adults were almost three times more likely to report 
high levels of anxiety symptoms at the beginning of the COVID-19 
pandemic compared to a year earlier. In line with prior research 
(Daly et al., 2021a) the sharpest increases in anxiety were found in 
young adults and women, groups that were disproportionally impacted 
by business closures at the onset of the pandemic (ILO, 2020). 
Figure 1. Proportion of U.S. adults with anxiety in 2019 and throughout the COVID-19 pandemic in 2020. 
Note: Estimates from 2019 are derived from the National Health Interview Survey (NHIS) (N = 30,915) and 2020 estimates are derived from the Understanding 
America Study (N = 8,022, observations = 121,768). 
Table 1 
Comparisons of the prevalence of anxiety in 2019 and at six time-points during the COVID-19 pandemic from March 10th to December 31st 2020.  
Date / Year Jan - Dec 2019 Mar 10-31, 2020 Apr 1-14, 2020 Apr 15-28, 2020 Apr 29-May 12 
2020 
May 13-26, 2020 Dec 9-31, 2021 
N 30,915 6,813 5,392 6,199 6,301 6,239 5,840  
% [95% CI] % [95% CI] % [95% CI] % [95% CI] % [95% CI] % [95% CI] % [95% CI] 
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However, anxiety levels recovered quickly in the weeks following the 
initiation of stay-at-home orders, and plateaued after lockdown re-
strictions were lifted in most states in May, 2020 (Tolbert et al., 2020). 
Decreases in anxiety were almost universally observed across de-
mographic groups, a trend that corroborates emerging evidence from 
the U.K indicating that the deterioration in mental health in April 2020 
(Daly et al., 2021a) was followed by stabilization and recovery in the 
months immediately afterwards (Daly and Robinson, 2020a). Two 
additional large-scale studies of U.K. adults have also shown that anxiety 
levels declined following the pandemic onset (Fancourt et al., 2020, 
O’Connor et al., 2020). 
It is feasible that this decline occurred because the initial sharp rise in 
anxiety like symptoms was part of a functional and adaptive response to 
a major stressful and sizeable threat to society (Bateson et al., 2011). In 
line with this explanation, people likely adapted to the perceived threat 
posed by the pandemic and there is evidence that people were less 
fearful of the virus as knowledge about its transmission and effects was 
communicated (Daly and Robinson, 2020b), which in turn may explain 
why anxiety like symptoms then decreased across the course of 2020. 
Despite this large-scale recovery, anxiety levels did not return to 
their pre-pandemic baseline level for most groups. In the general pop-
ulation the prevalence of high levels of anxiety remained over 3 per-
centage points above 2019 levels from May to December 2020. The 
anxiety levels of young adults were persistently elevated above 2019 
levels suggesting that this group may have been particularly vulnerable 
to longer-term pandemic effects. This may reflect an enduring impact of 
the psychosocial consequences of the pandemic over this period. How-
ever, it is also possible that differences in the mode of administration or 
sampling strategies between the NHIS and UAS could partly explain this 
difference. Distinguishing between these possibilities will now be 
important. Further, given high levels of anxiety were observed in a range 
of countries at the onset of the pandemic (Vindegaard et al., 2020; 
Winkler et al., 2020) testing whether anxiety symptoms declined in a 
similar fashion in other nations and the role of the COVID-19 situation in 
shaping trajectories of anxiety will now be crucial. 
Strengths of the current study include the use of two large-scale 
probability-based surveys of U.S. adults and the examination of longi-
tudinal changes in anxiety levels during the COVID-19 pandemic. 
However, it is important to note that the NHIS and UAS samples differ in 
their sampling and mode of administration which may bias comparisons 
between samples. Further, while the GAD-2 is well-validated for 
detecting high levels of anxiety, longer scales would shed light on the 
robustness of the national trends identified in this study. 
Taken together our findings suggest that while the pandemic may 
have induced substantial increases in anxiety like symptoms, these in-
creases were largely transient. This conclusion is consistent with the 
findings of a recent review and meta-analysis examining anxiety 
symptoms before vs. during the pandemic (Robinson et al., 2021). While 
prolonged major fluctuations in mental health may not have occurred, it 
remains possible that a small but enduring effect of the pandemic could 
have persisted in the population. Therefore, it will be important to 
ensure that community mental health treatment services are accessible, 
particularly for young people who are already at high risk of developing 
mental health difficulties (Auerbach et al., 2018) and may be experi-
encing significant anxiety symptoms for the first time. 
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